351 related articles for article (PubMed ID: 530845)
21. An improved method to determine renal function using inulin and p-aminohippurate (PAH) steady-state kinetic modeling.
Schumann L; Wüstenberg PW
Clin Nephrol; 1990 Jan; 33(1):35-40. PubMed ID: 2302868
[TBL] [Abstract][Full Text] [Related]
22. [An experimental study of PAH clearance in chronic unilateral and completely obstructed kidney].
Onmura Y
Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):662-7. PubMed ID: 8492509
[TBL] [Abstract][Full Text] [Related]
23. Differences in excretion of hippurate, as a metabolite of benzoate and as an administered species, in the single-pass isolated perfused rat kidney explained.
Geng W; Pang KS
J Pharmacol Exp Ther; 1999 Feb; 288(2):597-606. PubMed ID: 9918564
[TBL] [Abstract][Full Text] [Related]
24. [Clearance determination with 131I-labelled hippurate (author's transl)].
Gabriel R; Hoffmann H; Eismann D; Orlick M; Heinrichs HJ
MMW Munch Med Wochenschr; 1980 Oct; 122(41):1423-6. PubMed ID: 6780825
[TBL] [Abstract][Full Text] [Related]
25. Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine with ERPF, GFR and ERPF/GFR ratio determination using colorimetric analysis.
Farthing D; Sica DA; Fakhry I; Larus T; Ghosh S; Farthing C; Vranian M; Gehr T
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):267-72. PubMed ID: 16169291
[TBL] [Abstract][Full Text] [Related]
26. Clinical applications of a kinetic model of hippurate distribution and renal clearance.
DeGrazia JA; Scheibe PO; Jackson PE; Lucas ZJ; Fair WR; Vogel JM; Blumin LJ
J Nucl Med; 1974 Feb; 15(2):102-14. PubMed ID: 4589731
[No Abstract] [Full Text] [Related]
27. Angiotensin-converting enzyme inhibition-induced changes in hippurate renography and renal function in renovascular hypertension.
Visscher CA; de Zeeuw D; de Jong PE; Piers DA; Beekhuis H; Groothuis GM; Huisman RM
J Nucl Med; 1996 Mar; 37(3):482-8. PubMed ID: 8772652
[TBL] [Abstract][Full Text] [Related]
28. [New method for the determination of renal clearance of para-aminohippuric acid. Simplified method without urine collection].
Chanard J; Masson M
Nouv Presse Med; 1972 Jul; 1(28):1905-8. PubMed ID: 5054566
[No Abstract] [Full Text] [Related]
29. Comparison of different methods of clearance determination.
Buttermann G; Wolf IH; Heidenreich P; Oberdorfer M; Kuhlmann H; Czempiel H; Hör G; Pabst HW
Contrib Nephrol; 1978; 11():55-61. PubMed ID: 699595
[TBL] [Abstract][Full Text] [Related]
30. [Development of combined inulin/p-aminohippuric acid (PAH) slow release implantation tablets for clearance determination in awake rats].
Korsatko W; Sadjak A; Gall P; Supanz S
Pharmazie; 1987 May; 42(5):324-7. PubMed ID: 3671443
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-labeled p-aminohippuric acid analog: a new renal agent: concise communication.
Chervu LR; Sundoro BM; Blaufox MD
J Nucl Med; 1984 Oct; 25(10):1111-5. PubMed ID: 6548256
[TBL] [Abstract][Full Text] [Related]
32. Rapid method for the measurement of differential renal function: validation.
Chachati A; Meyers A; Godon JP; Rigo P
J Nucl Med; 1987 May; 28(5):829-36. PubMed ID: 3553463
[TBL] [Abstract][Full Text] [Related]
33. Excretory function after unilateral renal denervation and administration of propranolol to unanaesthetized dogs.
Girchev R; Toneva Z; Natcheff N
Acta Physiol Hung; 1989; 73(1):53-60. PubMed ID: 2565646
[TBL] [Abstract][Full Text] [Related]
34. Effect of unconjugated bilirubin on the uptake of p-aminohippuric acid by the isolated perfused rat kidney.
Comín EJ; Elías MM; Grossman M; Rodriguez Garay EA
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):169-72. PubMed ID: 7313301
[TBL] [Abstract][Full Text] [Related]
35. [Experimental studies on the regeneration capability and prognosis of hydronephrosis].
Wieland W; Peters HP; Staehler G; Moser FA; Brendel W
Urologe A; 1985 Nov; 24(6):323-5. PubMed ID: 4090127
[TBL] [Abstract][Full Text] [Related]
36. [Dose- and age-dependence of the renal tubular transport of p-aminohippuric acid (PAH) in rats after injection of single doses].
Bräunlich H; Fleck C; Bajanowski T; Miosge W
Pharmazie; 1983 Jul; 38(7):483-5. PubMed ID: 6634917
[TBL] [Abstract][Full Text] [Related]
37. [Investigation of renal clearance in nuclear medicine (author's transl)].
Oberhausen E
Radiologe; 1981 Dec; 21(12):548-52. PubMed ID: 6796995
[TBL] [Abstract][Full Text] [Related]
38. Antibiotics and chemotherapeutics in renal lymph. An experimental study in dogs.
Naber KG; Madsen PO; Maroske D; Bichler KH
Invest Urol; 1976 Jul; 14(1):23-7. PubMed ID: 955846
[TBL] [Abstract][Full Text] [Related]
39. [Concentration of p-aminohippuric acid in the serum and kidney tissue during stimulation of renal excretion of foreign materials].
Storch R; Bräunlich H
Acta Biol Med Ger; 1977; 36(2):237-44. PubMed ID: 906735
[TBL] [Abstract][Full Text] [Related]
40. Comparative studies on the determination of the differential effective renal plasma flow with 131-I-hippuran and PAH.
Mushmov D; Brailska M; Budevski G; Salambashev L; Dimitrova S
Int Urol Nephrol; 1973 Apr; 5(2):205-8. PubMed ID: 4774524
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
